Paradigm Medical Industries Expands, Strengthens Global Sales and Marketing Effort.

SALT LAKE CITY -- In a move to strengthen and significantly expand its global sales and marketing effort, Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, today named Steven Davis, Vice-President, Sales and Marketing. Mr. Davis has more than 20 years' experience in the ophthalmic industry, where he has served in numerous senior sales and marketing positions.

"Steve will be in charge of all sales-international and domestic-as well as product marketing," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "His appointment to the Company will allow me to concentrate fully on Paradigm Medical's strategy and its implementation."

Paradigm Medical also disclosed that Chuck Pritchard has rejoined the Company, as Domestic Sales Manager. Mr. Pritchard previously worked at Paradigm Medical for eight years, and is an expert in Ultrasound BioMicroscope (UBM) and Blood Flow Analyzer (BFA) application and marketing.

Finally, Paradigm Medical has entered into an agreement for product support and evaluation with Dr. Richard K. Simonds, who operates a practice in Mira Mesa, California. In November 2005, Dr. Simonds was appointed to the California Board of Optometry. He is certified to treat Primary Open Angle Glaucoma. "Dr. Simonds has been a user of Paradigm Medical and Dicon products for many years and is an advocate of our product being one of the best Visual Field Analyzers available today," Mr. Cannefax added.

Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed "The UBM Company" (Ultrasound BioMicroscope). Contact us at 801-977-8970 or visit us at www.paradigm-medical.com.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.